51. Cost-effectiveness of active case-finding of household contacts of pulmonary tuberculosis patients in a low HIV, tuberculosis-endemic urban area of Lima, Peru
- Author
-
SHAH, L, ROJAS, M, MORI, O, ZAMUDIO, C, KAUFMAN, JS, OTERO, L, GOTUZZO, E, SEAS, C, and BREWER, TF
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Rare Diseases ,Clinical Research ,Comparative Effectiveness Research ,Emerging Infectious Diseases ,Cost Effectiveness Research ,Tuberculosis ,Infectious Diseases ,HIV/AIDS ,Infection ,Good Health and Well Being ,Cost-Benefit Analysis ,Diagnostic Tests ,Routine ,Endemic Diseases ,Family Characteristics ,HIV Infections ,Humans ,Mass Screening ,Peru ,Tuberculosis ,Pulmonary ,Case-finding ,community epidemics ,cost-effectiveness ,public health ,tuberculosis ,Public Health and Health Services ,Epidemiology ,Veterinary sciences ,Clinical sciences - Abstract
We compared the cost-effectiveness (CE) of an active case-finding (ACF) programme for household contacts of tuberculosis (TB) cases enrolled in first-line treatment to routine passive case-finding (PCF) within an established national TB programme in Peru. Decision analysis was used to model detection of TB in household contacts through: (1) self-report of symptomatic cases for evaluation (PCF), (2) a provider-initiated ACF programme, (3) addition of an Xpert MTB/RIF diagnostic test for a single sputum sample from household contacts, and (4) all strategies combined. CE was calculated as the incremental cost-effectiveness ratio (ICER) in terms of US dollars per disability-adjusted life years (DALYs) averted. Compared to PCF alone, ACF for household contacts resulted in an ICER of $2155 per DALY averted. The addition of the Xpert MTB/RIF diagnostic test resulted in an ICER of $3275 per DALY averted within a PCF programme and $3399 per DALY averted when an ACF programme was included. Provider-initiated ACF of household contacts in an urban setting of Lima, Peru can be highly cost-effective, even including costs to seek out contacts and perform an Xpert/MTB RIF test. ACF including Xpert MTB/RIF was not cost-effective if TB cases detected had high rates of default from treatment or poor outcomes.
- Published
- 2017